` Comparison: RP vs 207940 - Alpha Spread
Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

RP
vs
207940

Over the past 12 months, RP has underperformed Samsung Biologics Co Ltd, delivering a return of 0% compared to the Samsung Biologics Co Ltd's 0% growth.

Valuation Growth Profitability Solvency Stocks Performance
Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
RP
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
RP 207940
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

RP Intrinsic Value
HIDDEN
Show
Samsung Biologics Co Ltd Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Replicel Life Sciences Inc
XTSX:RP
0.015 CAD
Samsung Biologics Co Ltd
KRX:207940
999 999.9999 KRW
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
RP, 207940

RP
207940
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Replicel Life Sciences Inc
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
RP, 207940

RP
207940
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Replicel Life Sciences Inc
XTSX:RP
Samsung Biologics Co Ltd
KRX:207940
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

RP
0%
Samsung Biologics Co Ltd
56.3%

Operating Margin

RP
0%
Samsung Biologics Co Ltd
36.6%

Net Margin

RP
0%
Samsung Biologics Co Ltd
29%

FCF Margin

RP
0%
Samsung Biologics Co Ltd
13.1%

ROE

RP
-10.2%
Samsung Biologics Co Ltd
14%

ROA

RP
-9.8%
Samsung Biologics Co Ltd
9.3%

ROIC

RP
423.2%
Samsung Biologics Co Ltd
10.1%

ROCE

RP
-10.2%
Samsung Biologics Co Ltd
14.9%

Solvency Comparison

Replicel Life Sciences Inc
Equity Waterfall
Assets
Liabilities
Equity
What is Equity Waterfall?
Samsung Biologics Co Ltd
Equity Waterfall
Assets
Liabilities
Equity
What is Equity Waterfall?
No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
RP, 207940

Loading
RP
207940
Add Stock
www.alphaspread.com
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RP, 207940

Performance Gap Between RP and 207940
HIDDEN
Show

Performance By Year
RP, 207940

Loading
RP
207940
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare RP to other stocks
0KHE
PerkinElmer Inc
P
More expensive
vs RP
TMO
Thermo Fisher Scientific...
Cheaper
vs RP
DHR
Danaher Corp
More expensive
vs RP
LONN
Lonza Group AG
Cheaper
vs RP
Unlock Full Access to Alpha Spread
Create Free Account
ALPHA SPREAD
Follow us
Join more than 320,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett